α-ガラクトシルセラミドをパルスした樹状細胞の肝内投与により肝腫瘍は抑制される

スポンサーリンク

概要

• 論文の詳細を見る
• Blackwell Publishingの論文

著者

• TATSUMI Tomohide

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• YAMAGUCHI Shinjiro

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• Takehara Tetsuo

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Takehara Tetsuo

  大阪大学 医学系研究科消化器内科

• Toyama Tetsuya

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Toyama T

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Takehara Tetsuo

  Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine

• Yamaguchi Shinjiro

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Tatsumi Tomohide

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• TAKEHARA Tetsuo

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

関連論文

• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
• Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
• Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
• Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
• Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
• Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
• Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
• Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
• Molecular Pathogenesis of Viral Hepatitis
• Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
• The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
• Juvenile hepatocellular carcinoma with congestive liver cirrhosis
• Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
• Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
• α-ガラクトシルセラミドをパルスした樹状細胞の肝内投与により肝腫瘍は抑制される
• Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis
• Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice
• CLONING OF ent-KAURENE SYNTHASE B cDNA FROM PUMPKIN(Cucurbita maxima L. )
• Antiviral therapy for chronic hepatitis C : past, present, and future
• Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients
• Fas and Fas ligand in human hepatocellular carcinoma
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
• Adipocytokines and liver disease
• Effects of Electroacupuncture Stimulation Applied to Limb and Back on Mesenteric Microvascular Hemodynamics
• Effects of Electrical Stimulation of the Dorsal Skin on Systemic and Mesenteric Microvascular Hemodynamics in Anesthetized Rats
• EFFECTS OF ELECTRO-ACUPUNCTURE AND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION ON MICROCIRCULATORY HEMODYNAMICS IN ANESTHETIZED RATS
• Molecular Pathogenesis of Viral Hepatitis
• cDNA Cloning and Characterization of a Gibberellin-Responsive Gene in Hypocotyls of Cucumis sativus L.
• Bcl-xL阻害薬ABT-737はソラフェニブと併用した時に肝癌細胞のアポトーシスを誘導し増殖を抑制する
• Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
• Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
• Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
• Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
• Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
• Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
• Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
• Reply to the letter by L. Czako et al. regarding "Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group"
• Hepatitis B virus reactivation associated with temozolomide for malignant glioma : a case report and recommendation for prophylaxis
• Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
• Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines
• Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
• Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction : Health check-up study of Japanese men
• Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice

もっと見る 閉じる

スポンサーリンク